-+ 0.00%
-+ 0.00%
-+ 0.00%

ZENTALIS PHARMACEUTICALS - MEDIAN OVERALL SURVIVAL OF 15.8 MONTHS WITH AZENOSERTIB IN CYCLIN E1-POSITIVE PROC

路透·10/18/2026 22:07:59

请登录查看新闻详情